Association of metformin administration after septic shock with short-term and long-term survival in septic shock patients with diabetes
In septic shock patients with type 2 diabetes mellitus, metformin administration within 48 h was associated with lower 90-day and 365-day mortality. While these findings suggest potential benefits of metformin administration after septic shock, further large, multicenter studies are warranted.
Authors
- Bo-Yeong Jin (ORCID: https://orcid.org/0000-0002-5728-2147)
- Hanjin Cho
- Jong-Hak Park (ORCID: https://orcid.org/0000-0001-9481-6358)
- Sukyo Lee (ORCID: https://orcid.org/0000-0002-7105-1951)
- Sejoong Ahn (ORCID: https://orcid.org/0000-0002-6003-2552)
- Woo Sik Kim (ORCID: https://orcid.org/0000-0002-4208-8907)
- Sungwoo Moon
Institutions
- Seoul National University (KR)
- Korea University (KR)
- Ansan University (KR)
Publication Details
- Journal
- Annals of Intensive Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1186/s13613-025-01490-8
- Citations
- 4
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Korea University